P. Boyle[1], P. Autier[2], H. Bartelink[3], J. Baselga[4], P. Boffetta[5], J. Burn[6], H.J.G. Burns[7], L. Christensen[8], L. Denis[9], M. Dicato[10], V. Diehl[11], R, Doll[12], S. Franceschi[13], C.R. Gillis[14], N. Gray[15], L. Griciute[16], A. Hackshaw[17], M. Kasler[18], M. Kogevinas[19], S. Kvinnsland[20], C. La Vecchia[21], F. Levi[22], J.G. McVie[23], P. Maisonneuve[24], J.M. Martin-Moreno[25], J. Newton Bishop[26], F. Oleari[27], P. Perrin[28], M. Quinn[29], M. Richards[30], U. Ringborg[31], C. Scully[32], E. Siracka[33], H. Storm[34], M. Tubiana[35], T. Tursz[36], U. Veronesi[37], N. Wald[38], W. Weber[39], D.G. Zaridze[40], W. Zatoński[41] i H. zur Hausen[42]

1. Department of Epidemiology and Biostatistics, European Institute of Oncology, Mediolan, Włochy;
2. Centre for Research on Epidemiology and Health Information Systems (CRESIS), Centre de Recherche Public de la Santé, Luksemburg;
3. Professor and Chairman, Radiotherapy Department, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam, Holandia;
4. Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron, Barcelona, Hiszpania;
5. Chief, Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, Lyon, Francja;
6. Cancer Family Network, Cancer Research UK, University of Newcastle, Newcastle, Wielka Brytania;
7. Chief Administrative Medical Officer, Greater Glasgow Health Board, Glasgow, Wielka Brytania;
8. President, The Association of European Cancer Leagues, Oslo, Norwegia;
9. Oncology Centre Antwerp, Antwerpia, Belgia;
10. Hematology-Oncology, Centre Hospitalier, Luksemburg;
11. Med. Klinic 1, Universität zu Köln, Kolonia, Niemcy;
12. Clinical Trial Service Unit, Cancer Research UK Cancer Studies Unit, Radcliffe Infirmary, Oxford, Wielka Brytania;
13. Chief, Field and Intervention Studies Unit, IARC, Lyon, Francja;
14. Scientific Coordinator, Department of Epidemiology and Biostatistics, European Institute of Oncology, Mediolan, Włochy;
15. Department of Epidemiology and Biostatistics, European Institute of Oncology, Mediolan, Włochy;
16. Lithuanian Oncology Center, Wilno, Litwa;
17. Deputy Director, Cancer Research UK & UCL Cancer Trials Centre, Stephenson House, Londyn, Wielka Brytania;
18. Director, National Institute of Oncology, Budapeszt, Węgry;
19. Department of Epidemiology and Public Health, Institut Municipal d'Investigacio M?dica (IMIM), Barcelona, Hiszpania;
20. Department of Oncology, Haukaland Hospital, Bergen, Norwegia;
21. Istituto di Ricerche Farmacologiche Mario Negri, Mediolan, Włochy;
22. Director, Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, Lozanna, Szwajcaria;
23. Scientific Coordinator, Department of Epidemiology and Biostatistics, European Institute of Oncology, Mediolan, Włochy;
24. Unit of Clinical Epidemiology, Department of Epidemiology and Biostatistics, European Institute of Oncology, Mediolan, Włochy;
25. Director-General of Public Health, Ministerio de Sanidad y Consumo, Madryt, Hiszpania;
26. Genetic Epidemiology Division, Cancer Research UK, St James's University Hospital, Leeds, Wielka Brytania;
27. Ministero della Sanita', Rzym, Włochy;
28. Chairman, Department of Urology, Hopital de l'Antiquaille, Lyon, Francja;
29. Director, National Cancer Intelligence Centre, Office for National Statistics, B6/02, 1 Drummond Gate, Londyn, Wielka Brytania;
30. National Cancer Director, St Thomas' Hospital, Londyn, Wielka Brytania;
31. Department of Oncology, Radiumhemmet, Karolinska Hospital, Sztokholm, Szwecja;
32. Dean and Director of Studies and Research, Eastman Dental Institute for Oral Health Care Sciences and International Centres for Excellence in Dentistry, University of London, Eastman Dental Institute, Londyn, Wielka Brytania;
33. President, Liga proti rakovine SR, Bratysława, Słowacja;
34 Danish Cancer Society, Director Cancer Prevention and Documentation, Kopenhaga, Dania;
35. President du Centre Antoine Beclere, Centre Antoine Beclere, Faculte' de Medicine, Paryż, Francja;
36. Director, Institut Gustave Roussy, Villejuif, Francja;
37. Scientific Director, European Institute of Oncology, Mediolan, Włochy;
38. The Medical College of St Bartholomew's Hospital, Wolfson Institute of Preventive Medicine, Department of Epidemiology, Londyn, Wielka Brytania; 39Schweizerische Krebsliga, Berno, Szwajcaria;
40. Director, Institute of Carcinogenesis, Deputy Director, Cancer Research Centre RAMS, Moskwa, Federacja Rosyjska;
41. Zakład Epidemiologii i Prewencji Nowotworów, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warszawa, Polska;
42. Director, German Cancer Research Center (DKFZ), Heidelberg, Niemcy

tłum. Magdalena Chechlińska